Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Caution with AI-generated content in biomedicine

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature Medicine 29, 532 (2023)


Competing interests

A.Z. is the founder and CEO of Insilico Medicine, a clinical-stage biotechnology company developing generative artificial intelligence and robotic platforms for drug discovery; holds multiple granted patents in generative biology and generative chemistry; and is an adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links